Compare Amphastar Pharmaceuticals Inc (AMPH) vs Flagstar Bank NA (FLG) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Flagstar Bank (FLG) trades at $15.09, up 2.17% today, with a neutral technical outlook and bullish analyst consensus. The stock shows improving fundamentals with two consecutive quarterly earnings beats and a modest dividend. Recent news highlights technology transformation and executive leadership stability, while financial trends indicate progress toward profitability despite current negative margins.

The outlook suggests moderate upside potential with a $17.05 consensus price target, though risks include ongoing negative profitability and high interest expenses. The bank's turnaround progress and improved credit quality provide catalysts, but investors should weigh the balance between valuation discount and execution risks in the competitive banking sector.